Insulet
PODD
$159.49
Share price
-2.67%
Change (1 day)
-38.86%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Market capitalization of Insulet (PODD)
Market cap: $11.13 Billion
As of September 2023 Insulet has a market cap of $11.13 Billion. This makes Insulet the world's 1368th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Insulet from 2007 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $11.13 B | -45.53% |
| 2022 | $20.44 B | 11.42% |
| 2021 | $18.35 B | 8.88% |
| 2020 | $16.85 B | 57.04% |
| 2019 | $10.73 B | 128.59% |
| 2018 | $4.69 B | 16.93% |
| 2017 | $4.01 B | 85.55% |
| 2016 | $2.16 B | 0.48% |
| 2015 | $2.15 B | -16.96% |
| 2014 | $2.59 B | 27.38% |
| 2013 | $2.03 B | 98.38% |
| 2012 | $1.02 B | 14.99% |
| 2011 | $0.89 B | 26.71% |
| 2010 | $0.70 B | 30.64% |
| 2009 | $0.53 B | 172.45% |
| 2008 | $0.19 B | -67.12% |
| 2007 | $0.60 B |
End of Day market cap according to different sources
On Sep 29th, 2023 the market cap of Insulet was reported to be:
$11.13 Billion
$11.13 Billion
$11.13 Billion
$11.13 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $375.59 B | 3,272.89% | 🇺🇸 USA |
 Abbott Laboratories ABT | $168.06 B | 1,409.28% | 🇺🇸 USA |
 Medtronic MDT | $104.26 B | 836.27% | 🇮🇪 Ireland |
 Eli Lilly LLY | $509.89 B | 4,478.89% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $1.35 B | -87.86% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.87 B | -74.21% | 🇺🇸 USA |
 DexCom DXCM | $9.06 B | -18.56% | 🇺🇸 USA |